IPP Bureau
Mylab Discovery Solutions acquires Sanskritech in an all-cash deal
By IPP Bureau - September 20, 2021
The investment will be used to develop affordable Point of Care labs with 70+ tests. Mylab will start deploying systems with its lab partners from Nov 2021
.jpg "India extends concession on life-saving Covid-19 drugs till December 2021")
India extends concession on life-saving Covid-19 drugs till December 2021
By IPP Bureau - September 18, 2021
The council has also reduced the GST to 5 per cent on a few more Covid-19 medicines
Samhita and Cipla collaborate to study the role of pharmacists in healthcare
By IPP Bureau - September 18, 2021
Over 61 per cent of pharmacists stated that they aim to improve their knowledge and medical skills while 76 per cent collaborated with healthcare players to improve the outcome for their patients
Union Minister Jitendra Singh launch free telemedicine facility
By IPP Bureau - September 18, 2021
Telemedicine services like SAATH and E-Sanjeevani add a meta-layer to the primary health sector, thus helping upgrade the entire health care system of India
Roche receives positive CHMP opinion for Gavreto
By IPP Bureau - September 18, 2021
If approved, Gavreto will be the first and only targeted treatment approved by the EMA that includes first-line treatment of people with RET fusion-positive advanced NSCLC
Pharmexcil exhibition and conference on Sept 21-22
By IPP Bureau - September 18, 2021
The event will include an exhibition and sector-wise sessions for two days with participation by officials from the Ministry of Commerce, export promotion councils and members of the industry
Zydus Cadila receives final nod for anti-depressant
By IPP Bureau - September 18, 2021
The medicine helps restore the balance of certain natural substances (serotonin) in the brain
Apollo Hospital Chennai completes India’s first robotic bariatric surgery
By IPP Bureau - September 18, 2021
This procedure is incidentally the first robotic bariatric surgery in the world to be performed in just three ports
Excision receives U.S. FDA clearance for first-in-human CRISPR Phase I/II trail for HIV
By IPP Bureau - September 18, 2021
Initiation of EBT-101 Phase 1/2 clinical trial expected later this year
QCI institutes Prof. SK Joshi laboratory excellence award
By IPP Bureau - September 17, 2021
This award is open to all currently operational laboratories pertaining to testing, calibration & medical including their proficiency testing providers & reference material producers located in India
LifeCell receives DCGI approval for Mesocel clinical trial to treat Covid-19
By IPP Bureau - September 17, 2021
The clinical trial, to be conducted in two phases, will evaluate the safety and efficacy of Mesocel for the treatment of patients with moderate to severe Covid-19
Cosara Diagnostics receives CDSCO licence to manufacture Dengue test kit
By IPP Bureau - September 17, 2021
It tests for the presence or absence of ribonucleic acid (RNA) of Dengue (Type 1, 2 4) in serum or plasma from patients suspected of dengue viral infection.
PharmaZell and Novasep come together to form a formidable API and CDMO platform
By IPP Bureau - September 17, 2021
They enter into exclusive negotiations in a new drive to create a technology-driven leader for complex small molecules and ADCs of global scale
Canada approves Moderna’s Covid-19 vaccine
By IPP Bureau - September 17, 2021
In the final analysis of Phase 3 COVE study data, SPIKEVAX showed 93% efficacy, with the efficacy remaining durable through six months after the administration of the second dose
Biocon Biologics to offer Serum Institute of Life Sciences 15 pc stake at US $ 4.9 billion valuation
By IPP Bureau - September 17, 2021
BB will have access to 100 million doses of vaccines annually and commercialization rights of the SILS vaccine portfolio for global markets
